Variability of Contact Process in Complex Networks

We study numerically how the structures of distinct networks influence the epidemic dynamics in contact process. We first find that the variability difference between homogeneous and heterogeneous networks is very narrow, although the heterogeneous structures can induce the lighter prevalence. Contrary to non-community networks, strong community structures can cause the secondary outbreak of prevalence and two peaks of variability appeared. Especially in the local community, the extraordinarily large variability in early stage of the outbreak makes the prediction of epidemic spreading hard. Importantly, the bridgeness plays a significant role in the predictability, meaning the further distance of the initial seed to the bridgeness, the less accurate the predictability is. Also, we investigate the effect of different disease reaction mechanisms on variability, and find that the different reaction mechanisms will result in the distinct variabilities at the end of epidemic spreading.Comment: 6 pages, 4 figure

Discovery of gamma-ray emission from a strongly lobe-dominated quasar 3C 275.1

We systematically analyze the 6-year {\it Fermi}/LAT data of the lobe-dominated quasars (LDQs) in the complete LDQ sample from 3CRR survey and report the discovery of high-energy $\gamma$-ray emission from 3C 275.1. The $\gamma$-ray emission of 3C 207 is confirmed and significant variability of the lightcurve is identified. We do not find statistically significant $\gamma$-ray emission from other LDQs. 3C 275.1 is the known $\gamma$-ray quasar with the lowest core dominance parameter (i.e., $R=0.11$). We also show that both the northern radio hotspot and parsec jet models can reasonably reproduce the $\gamma$-ray data. The parsec jet model, however, is favored by the potential $\gamma$-ray variability at the timescale of months. We suggest that some dimmer $\gamma$-ray LDQs will be detected in the future and LDQs could contribute non-negligibly to the extragalactic $\gamma$-ray background.Comment: 26 pages, 10 figures, 3 tables; ApJ in pres

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis

ObjectiveThe aim of this study is to explore the prevalence and clinicopathological associations between anti-C1qA08 antibodies and anti-monomeric CRP (mCRP) a.a.35-47 antibodies and to explore the interaction between C1q and mCRP.MethodsNinety patients with biopsy-proven lupus nephritis were included from a Chinese cohort. Plasma samples collected on the day of renal biopsy were tested for anti-C1qA08 antibodies and anti-mCRP a.a.35-47 antibodies. The associations between these two autoantibodies and clinicopathologic features and long-term prognosis were analyzed. The interaction between C1q and mCRP was further investigated by ELISA, and the key linear epitopes of the combination of cholesterol binding sequence (CBS; a.a.35-47) and C1qA08 were tested by competitive inhibition assays. The surface plasmon resonance (SPR) was used to further verify the results.ResultsThe prevalence of anti-C1qA08 antibodies and anti-mCRP a.a.35-47 antibodies were 50/90 (61.1%) and 45/90 (50.0%), respectively. Levels of anti-C1qA08 antibodies and anti-mCRP a.a.35-47 antibodies were negatively correlated with serum C3 concentrations ((0.5(0.22-1.19) g/L vs. 0.39(0.15-1.38) g/L, P=0.002) and (0.48(0.44-0.88) g/L vs. 0.41(0.15-1.38) g/L, P=0.028), respectively. Levels of anti-C1qA08 antibodies were correlated with the score of fibrous crescents and tubular atrophy (r=-0.256, P=0.014 and r=-0.25, P=0.016, respectively). The patients with double positive antibodies showed worse renal prognosis than that of the double negative group (HR 0.899 (95% CI: 0.739-1.059), P=0.0336). The binding of mCRP to C1q was confirmed by ELISA. The key linear epitopes of the combination were a.a.35-47 and C1qA08, which were confirmed by competitive inhibition experiments and SPR.ConclusionThe combination of anti-C1qA08 and anti-mCRP a.a.35-47 autoantibodies could predict a poor renal outcome. The key linear epitopes of the combination of C1q and mCRP were C1qA08 and a.a.35-47. A08 was an important epitope for the classical pathway complement activation and a.a.35-47 could inhibit this process

Gene Clusters Located on Two Large Plasmids Determine Spore Crystal Association (SCA) in Bacillus thuringiensis Subsp. finitimus Strain YBT-020

Crystals in Bacillus thuringiensis are usually formed in the mother cell compartment during sporulation and are separated from the spores after mother cell lysis. In a few strains, crystals are produced inside the exosporium and are associated with the spores after sporulation. This special phenotype, named ‘spore crystal association’ (SCA), typically occurs in B. thuringiensis subsp. finitimus. Our aim was to identify genes determining the SCA phenotype in B. thuringiensis subsp. finitimus strain YBT-020. Plasmid conjugation experiments indicated that the SCA phenotype in this strain was tightly linked with two large plasmids (pBMB26 and pBMB28). A shuttle bacterial artificial chromosome (BAC) library of strain YBT-020 was constructed. Six fragments from BAC clones were screened from this library and discovered to cover the full length of pBMB26; four others were found to cover pBMB28. Using fragment complementation testing, two fragments, each of approximately 35 kb and located on pBMB26 and pBMB28, were observed to recover the SCA phenotype in an acrystalliferous mutant, B. thuringiensis strain BMB171. Furthermore, deletion analysis indicated that the crystal protein gene cry26Aa from pBMB26, along with five genes from pBMB28, were indispensable to the SCA phenotype. Gene disruption and frame-shift mutation analyses revealed that two of the five genes from pBMB28, which showed low similarity to crystal proteins, determined the location of crystals inside the exosporium. Gene disruption revealed that the three remaining genes, similar to spore germination genes, contributed to the stability of the SCA phenotype in strain YBT-020. Our results thus identified the genes determining the SCA phenotype in B. thuringiensis subsp. finitimus

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial

Background. Several types of drugs have been recommended for the secondary prevention of myocardial infarction (MI). However, these conventional strategies have several limitations, such as low adherence, high cost, and side effects during long time use. Novel approaches to this problem are still needed. This trial aimed to test the effectiveness and safety of Qi-Shen-Yi-Qi Dripping Pills (QSYQ), a multi-ingredient Chinese patent medicine, for the secondary prevention of MI. Methods and Findings. A total of 3505 eligible patients were randomly assigned to QSYQ group (1746 patients) or aspirin group (1759). Patients took their treatments for 12 months. The final follow-up visit took place 6 months after the end of the trial drugs. The 12-month and 18-month estimated incidences of the primary outcome were 2.98% and 3.67%, respectively, in the QSYQ group. The figures were 2.96% and 3.81% in the aspirin group. No significant difference was identified between the groups. Conclusions. This trial did not show significant difference of primary and secondary outcomes between aspirin and QSYQ in patients who have had an MI. Though inconclusive, the result suggests that QSYQ has similar effects to aspirin in the secondary prevention of MI

Clinical analysis of 1 case of solitary brain metastases misdiagnosed as cerebral infarction

目的  通过报告1例误诊为脑梗死的单发性脑转移瘤患者的诊断过程，总结单发性脑转移瘤的临床、影像学特征及诊断治疗方法。方法  回顾性分析1例单发性脑转移瘤患者的诊断过程，并复习有关文献。结果  脑转移瘤常多发，单发者仅占25%，发病年龄以40～60岁多见，原发病灶以肺最常见。脑转移瘤常位于脑叶灰白质交界处，不同部位的肿瘤可出现不同的临床表现，影像学上常表现为“小病灶、大水肿”，与颅内原发肿瘤不易区分，头颅CT或 MRI增强检查并查到其他部位的原发肿瘤病灶后可确定诊断。目前主张单发性脑转移瘤应进行手术切除，术后辅以立体定向放射治疗和全脑放射治疗。结论  15%的脑转移瘤患者既往无肿瘤病史，因此诊断脑瘤后须在身体其他部位查找有无原发病灶，避免误诊、漏诊。对于中老年肺癌或其他恶性肿瘤患者，无论有无中枢神经系统症状，均应积极进行头颅CT甚至MRI检查，以发现较小的早期脑转移瘤病灶。对于易患肺癌人群，应该每年体检，进行胸部X线检查或低剂量CT筛查，以便早期发现肺癌病灶，早期治疗，防止肿瘤转移。Objective: To report 1 case was misdiagnosed as cerebral infarction solitary brain metastases (SBM) in patients with diagnosis process, and to summarize the clinical and imaging features of the SBM and its treatment. Methods: To retrospectively analyze the diagnostic process of 1 case of SBM patients, and to have literature review. Results: Patients with solitary and multiple brain metastases accounted for only 25%, the onset age was 40 ~ 60 years old, and the most common primary lesion is in lung. Brain metastases are often on the border, in between lobes grey matter. Different parts of the tumors can present different clinical manifestations. The diagnostic imaging is often shown as "small lesions, large edema", and intracranial primary tumor is not easy to distinguish, Head CT or MRI examination of tumors in other parts could confirm the diagnosis. Now that SBM should undergo surgery resection, postoperative supplemented by stereotactic radiotherapy and whole brain radiotherapy. Conclusions: 15% of the patients with brain metastases haven’t got previous medical history, the doctor is therefore must look for presence of primary lesions in other parts of the body for accurate diagnosis, to avoid the misdiagnosis and missed diagnosis. Middle-aged and elderly patients with lung cancer or other malignant tumor, regardless of the presence of the central nervous system symptoms, should carry on the head CT or MRI examination, and find smaller early brain metastatic lesions. People who are susceptible to lung cancer should have annual physical examination, chest X-ray or low dose CT screening for early detection of lung cancer lesions, early treatment and prevention of tumor metastasi

Variability in Estimated Glomerular Filtration Rate by Area under the Curve Predicts Renal Outcomes in Chronic Kidney Disease

Greater variability in renal function is associated with mortality in patients with chronic kidney disease (CKD). However, few studies have demonstrated the predictive value of renal function variability in relation to renal outcomes. This study investigates the predictive ability of different methods of determining estimated glomerular filtration rate (eGFR) variability for progression to renal replacement therapy (RRT) in CKD patients. This was a prospective observational study, which enrolled 1,862 CKD patients. The renal end point was defined as commencement of RRT. The variability in eGFR was measured by the area under the eGFR curve (AUC)%. A significant improvement in model prediction was based on the −2 log likelihood ratio statistic. During a median 28.7-month follow-up, there were 564 (30.3%) patients receiving RRT. In an adjusted Cox model, a smaller initial eGFR AUC%_12M (P<0.001), a smaller peak eGFR AUC%_12M (P<0.001), and a larger negative eGFR slope_12M (P<0.001) were associated with a higher risk of renal end point. Two calculated formulas: initial eGFR AUC%_12M and eGFR slope_12M were the best predictors. Our results demonstrate that the greater eGFR variability by AUC% is associated with the higher risk of progression to RRT